drugset / Trial / NCT04160910
5HTP Regulation Of Asthma In Children
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to learn more about if taking a supplement called 5-hydroxytryptophan (5HTP) can improve breathing and anxiety symptoms related to asthma. To help learn more subjects will either be assigned to a group that is taking the supplement (5HTP) or a group that is taking a placebo. This will be decided randomly. Later in the study subjects will crossover to the other group.There are 5 study visits over the course of about 12 weeks.
Timeline
- Start
- 2021-02-11
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 5-Hydroxytryptophan | Other / unclassified | 50 mg | — |
| Comparator | 5-Hydroxytryptophan | Other / unclassified | 100 mg | — |